Cue Biopharma (CUE) Short Interest Ratio & Short Volume $1.01 -0.01 (-0.98%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Cue Biopharma Short Interest DataCue Biopharma (CUE) has a short interest of 1.00 million shares. This marks a -6.54% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.3, indicating that it would take 1.3 days of the average trading volume of 453,447 shares to cover all short positions.Current Short Interest1,000,000 sharesPrevious Short Interest1,070,000 sharesChange Vs. Previous Month-6.54%Dollar Volume Sold Short$1.22 millionShort Interest Ratio1.3 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares63,350,000 sharesPercentage of Shares Shorted1.58%Today's Trading Volume624,251 sharesAverage Trading Volume453,447 sharesToday's Volume Vs. Average138% Short Selling Cue Biopharma? Sign up to receive the latest short interest report for Cue Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCUE Short Interest Over TimeCUE Days to Cover Over TimeCUE Percentage of Float Shorted Over Time Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Cue Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20241,000,000 shares $1.22 million -6.5%N/A1.3 $1.22 11/15/20241,070,000 shares $1.33 million -39.9%N/A1.4 $1.25 10/31/20241,780,000 shares $2.87 million -8.7%N/A2.6 $1.61 10/15/20241,950,000 shares $2.18 million -48.7%N/A2.9 $1.12 9/30/20243,800,000 shares $2.88 million +6.7%N/A6.6 $0.76 9/15/20243,560,000 shares $2.10 million +3.8%N/A8.2 $0.59 Get the Latest News and Ratings for CUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. 8/31/20243,430,000 shares $2.48 million -6.3%N/A7.7 $0.72 8/15/20243,660,000 shares $2.17 million -9.2%N/A8.1 $0.59 7/31/20244,030,000 shares $3.37 million +8.3%N/A8.9 $0.84 7/15/20243,720,000 shares $3.46 million -21.5%N/A9.7 $0.93 6/30/20244,740,000 shares $5.88 million +5.6%N/A12.3 $1.24 6/15/20244,490,000 shares $6.11 million +3.2%N/A15.9 $1.36 5/31/20244,350,000 shares $7.09 million -5.2%N/A15.5 $1.63 5/15/20244,590,000 shares $7.53 million -7.5%N/A15.5 $1.64 4/30/20244,960,000 shares $9.42 million +3.8%N/A17.2 $1.90 4/15/20244,780,000 shares $7.62 million +13.8%N/A18.7 $1.60 3/31/20244,200,000 shares $7.94 million +1.9%N/A15.8 $1.89 3/15/20244,120,000 shares $8.53 million +3.8%N/A14.7 $2.07 2/29/20243,970,000 shares $8.24 million +4.2%N/A12.7 $2.08 2/15/20243,810,000 shares $8.95 million +5.8%N/A10.8 $2.35 1/31/20243,600,000 shares $9.50 million -1.4%N/A10.6 $2.64 1/15/20243,650,000 shares $10.91 million +6.7%N/A10.1 $2.99 12/31/20233,420,000 shares $9.03 million +5.2%N/A9.4 $2.64 12/15/20233,250,000 shares $9.20 million +8.3%N/A9.5 $2.83 11/30/20233,000,000 shares $7.50 million -1.0%N/A10 $2.50 11/15/20233,030,000 shares $7.21 million -2.6%N/A11.8 $2.38 10/31/20233,110,000 shares $6.53 million +19.6%N/A10.2 $2.10 10/15/20232,600,000 shares $5.33 million +2.4%N/A8.2 $2.05 9/30/20232,540,000 shares $5.84 million +2.8%N/A6.7 $2.30 9/15/20232,470,000 shares $6.32 million +1.2%N/A5.2 $2.56 8/31/20232,440,000 shares $6.61 million -20.3%N/A5 $2.71 8/15/20233,060,000 shares $8.60 million -5.9%N/A6.2 $2.81 7/31/20233,250,000 shares $12.42 million +30.0%N/A7.1 $3.82 7/15/20232,500,000 shares $11.13 million +28.2%N/A5.5 $4.45 6/30/20231,950,000 shares $7.12 million +142.2%N/A5.4 $3.65 6/15/2023805,200 shares $3.12 million +10.1%N/A2.5 $3.87 5/31/2023731,600 shares $2.93 million +36.2%N/A3 $4.00 5/15/2023537,100 shares $2.39 million +1.0%N/A2.4 $4.45 4/30/2023531,900 shares $2.30 million -21.6%N/A2.8 $4.33 4/15/2023678,200 shares $2.36 million -10.5%N/A4.8 $3.48Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW 3/31/2023757,900 shares $2.71 million +35.4%N/A5.5 $3.57 3/15/2023559,600 shares $1.75 million +21.8%N/A4.4 $3.12 2/28/2023459,500 shares $1.29 million +4.9%N/A4.3 $2.80 2/15/2023438,000 shares $1.47 million -12.7%N/A3.9 $3.35 1/31/2023501,900 shares $1.72 million -22.1%N/A3.9 $3.42 1/15/2023644,500 shares $2.24 million +8.8%N/A5 $3.48 12/30/2022592,200 shares $1.69 million -17.4%N/A4.4 $2.85 12/15/2022717,000 shares $2.03 million -5.7%N/A4.4 $2.83 11/30/2022759,900 shares $2.93 million -12.9%N/A4.8 $3.86 11/15/2022872,100 shares $3.30 million -29.7%N/A5.4 $3.78 10/31/20221,240,000 shares $3.30 million -10.8%N/A7.6 $2.66 10/15/20221,390,000 shares $3.57 million -6.1%N/A8.2 $2.57 9/30/20221,480,000 shares $3.30 million -12.4%N/A8.2 $2.23 9/15/20221,690,000 shares $5.53 million -12.9%N/A6 $3.27 8/31/20221,940,000 shares $5.70 million No ChangeN/A6.1 $2.94 8/15/20221,940,000 shares $6.48 million -11.0%N/A5.5 $3.34 7/31/20222,180,000 shares $5.93 million -0.5%N/A5.5 $2.72 7/15/20222,190,000 shares $5.76 million -3.5%N/A5.2 $2.63 6/30/20222,270,000 shares $5.65 million -36.6%N/A4.8 $2.49 6/15/20223,580,000 shares $11.06 million -8.7%11.6%7.2 $3.09 5/31/20223,920,000 shares $15.17 million -4.6%12.7%8.3 $3.87 5/15/20224,110,000 shares $14.84 million No Change13.2%8.5 $3.61 4/30/20224,110,000 shares $16.28 million +15.1%13.2%8.5 $3.96 4/15/20223,570,000 shares $16.21 million +6.6%11.5%6.5 $4.54 3/31/20223,350,000 shares $16.35 million -12.3%10.8%6.3 $4.88 3/15/20223,820,000 shares $16.85 million +8.5%N/A8 $4.41 2/28/20223,520,000 shares $20.42 million +1.4%11.5%8.3 $5.80 2/15/20223,470,000 shares $24.64 million +29.0%11.3%8.2 $7.10 1/31/20222,690,000 shares $19.88 million +18.0%8.8%6.5 $7.39 1/15/20222,280,000 shares $22.69 million +11.8%7.4%6.9 $9.95 12/31/20212,040,000 shares $23.07 million +10.9%6.7%6.4 $11.31 12/15/20211,840,000 shares $20.68 million +10.8%6.0%5.8 $11.24 11/30/20211,660,000 shares $20.35 million -8.8%5.4%5.3 $12.26 11/15/20211,820,000 shares $32.49 million -9.9%5.9%6.1 $17.85 10/29/20212,020,000 shares $24.66 million +3.1%6.8%7.8 $12.21 10/15/20211,960,000 shares $24.70 million -2.5%6.6%7.8 $12.60 9/30/20212,010,000 shares $29.29 million -15.6%6.8%8.6 $14.57 9/15/20212,380,000 shares $28.82 million -4.8%8.0%10.6 $12.11 8/31/20212,500,000 shares $29.98 million -2.0%8.4%12.7 $11.99 8/13/20212,550,000 shares $28.33 million -3.4%8.6%12.7 $11.11 7/30/20212,640,000 shares $27.51 million -2.2%8.9%6.2 $10.42 7/15/20212,700,000 shares $27.51 million -0.4%9.1%6.2 $10.19 6/30/20212,710,000 shares $31.57 million +1.5%9.1%6 $11.65 6/15/20212,670,000 shares $35.22 million -6.3%9.0%5.9 $13.19 5/28/20212,850,000 shares $40.87 million -5.3%9.6%6.1 $14.34 5/14/20213,010,000 shares $38.98 million +16.2%N/A6 $12.95 4/30/20212,590,000 shares $31.11 million -10.4%N/A5.3 $12.01 4/15/20212,890,000 shares $36.04 million -8.0%N/A9.3 $12.47 3/31/20213,140,000 shares $36.11 million +11.0%N/A10.1 $11.50 3/15/20212,830,000 shares $44.57 million +1.8%N/A8.5 $15.75Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW 2/26/20212,780,000 shares $36.78 million +0.7%N/A8.8 $13.23 2/12/20212,760,000 shares $43.33 million -5.8%N/A9.3 $15.70 1/29/20212,930,000 shares $39.82 million +1.4%N/A10 $13.59 1/15/20212,890,000 shares $36.79 million +4.7%N/A9.8 $12.73 12/31/20202,760,000 shares $35.55 million +3.4%N/A10.4 $12.88 12/15/20202,670,000 shares $36.37 million -6.6%N/A10.4 $13.62 11/30/20202,860,000 shares $39.30 million -0.7%N/A10.8 $13.74 11/15/20202,880,000 shares $34.30 million +5.5%N/A10.3 $11.91 10/30/20202,730,000 shares $33.03 million +11.0%N/A10.3 $12.10 10/15/20202,460,000 shares $38.40 million -5.8%N/A9.3 $15.61 9/30/20202,610,000 shares $39.28 million +12.5%N/A9.9 $15.05 9/15/20202,320,000 shares $41.78 million +7.4%N/A7.5 $18.01 8/31/20202,160,000 shares $38.60 million -0.9%N/A6.6 $17.87 8/14/20202,180,000 shares $44.36 million +1.4%N/A7 $20.35 7/31/20202,150,000 shares $40.66 million +1.4%N/A6.3 $18.91 7/15/20202,120,000 shares $45.24 million +21.8%N/A5.9 $21.34 6/30/20201,740,000 shares $40.65 million +149.4%N/A4.7 $23.36 6/15/2020697,700 shares $19.19 million +12.2%N/A2 $27.50 5/29/2020622,000 shares $17.22 million -36.9%N/A1.9 $27.68 5/15/2020985,400 shares $25.25 million +12.1%N/A3.2 $25.62 4/30/2020878,900 shares $22.56 million -15.5%N/A3 $25.67 4/15/20201,040,000 shares $20.50 million -32.0%N/A3.9 $19.71 3/31/20201,530,000 shares $37.12 million +29.4%N/A6.5 $24.26 3/13/20201,182,000 shares $21.24 million +7.5%6.2%4.8 $17.97 2/28/20201,100,000 shares $13.38 million +4.8%5.8%4.3 $12.16 2/14/20201,050,000 shares $18.18 million -1.9%5.5%4.1 $17.31 1/31/20201,070,000 shares $20.26 million +9.5%6.2%4.1 $18.93 1/15/2020976,800 shares $19.54 million +2.8%5.6%4.2 $20.00 12/31/2019950,700 shares $14.46 million +3.9%5.5%4.5 $15.21 CUE Short Interest - Frequently Asked Questions What is Cue Biopharma's current short interest? Short interest is the volume of Cue Biopharma shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 1,000,000 shares of CUE short. Learn More on Cue Biopharma's current short interest. What is a good short interest ratio for Cue Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CUE shares currently have a short interest ratio of 1.0. Learn More on Cue Biopharma's short interest ratio. Is Cue Biopharma's short interest increasing or decreasing? Cue Biopharma saw a decline in short interest in November. As of November 30th, there was short interest totaling 1,000,000 shares, a decline of 6.5% from the previous total of 1,070,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cue Biopharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cue Biopharma: Chimerix, Inc. (0.81%), Atyr PHARMA INC (2.65%), Heron Therapeutics, Inc. (18.11%), Mersana Therapeutics, Inc. (7.08%), Fulcrum Therapeutics, Inc. (8.49%), Aurora Cannabis Inc. (8.05%), Lexeo Therapeutics, Inc. (9.24%), Fate Therapeutics, Inc. (9.97%), Zentalis Pharmaceuticals, Inc. (6.55%), DiaMedica Therapeutics Inc. (0.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Cue Biopharma stock? Short selling CUE is an investing strategy that aims to generate trading profit from Cue Biopharma as its price is falling. CUE shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cue Biopharma? A short squeeze for Cue Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CUE, which in turn drives the price of the stock up even further. How often is Cue Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CUE, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies CMRX Short Squeeze ATYR Short Squeeze HRTX Short Squeeze MRSN Short Squeeze FULC Short Squeeze ACB Short Squeeze LXEO Short Squeeze FATE Short Squeeze ZNTL Short Squeeze DMAC Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CUE) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cue Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cue Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
